DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages

Vibratory angioedema

Author: Dr Nicholas Van Rooij, Resident Medical Officer, The Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia. DermNet NZ Editor in Chief: Adjunct A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell. April 2020.


Vibratory angioedema — codes and concepts
open

What is vibratory angioedema?

Vibratory angioedema is a rare variant of chronic inducible urticaria. Exposure of the skin to vibration results in classical localised angioedema and erythema.

Vibratory angioedema is sometimes mistaken for vibratory urticaria. Vibratory urticaria is another form of chronic inducible urticaria, where vibration leads to wealing rather than angioedema [1].

Who gets vibratory angioedema?

Vibratory angioedema is one of the rarest forms of chronic inducible urticaria. There are few cases reported, and its prevalence is unknown.

Both genetic and acquired variants of vibratory angioedema have been reported. The hereditary type has been observed to have an autosomal dominant pattern of inheritance [2,3].

What causes vibratory angioedema?

The pathophysiology of vibratory angioedema is not fully understood. Symptoms are presumed to be triggered by histamine release from the activation and degranulation of mast cells stimulated by vibration.

Familial cases have been associated with a mutation in the ADGRE2 gene, resulting in mast cell sensitisation to vibration-induced degranulation [4].

A number of associated triggers have been documented, including:

  • Power-tools, such as drills, jack-hammers, and metal grinders
  • Motorcycling
  • Lawn mowing
  • Horseback riding
  • Towelling or massaging
  • Playing musical instruments, such as saxophone and trumpet
  • Snoring [5–7].

Anaphylaxis has also been documented in response to full-body vibratory massage [8].

What are the clinical features of vibratory angioedema?

The clinical features of vibratory angioedema are localised angioedema, erythema, and pruritus after a vibratory stimulus.

  • The most commonly implicated areas are those with the highest exposure to a stimulus, typically the hands.
  • The intensity and duration of the vibration stimulus are usually proportional to the severity of the symptoms.
  • Vibratory angioedema is distinct from other forms of chronic inducible urticaria that cause wealing.
  • Skin contact with a vibration stimulus results in symptoms within 10 minutes.
  • The peak in severity is at 4–6 hours, with complete resolution of vibratory angioedema within 24 hours.

In rare instances, a patient may also experience systemic symptoms following prolonged or extensive exposure to vibration, including:

  • Generalised erythema
  • Headache
  • Dizziness
  • Tachycardia
  • Hypotension [4].

What are the complications of vibratory angioedema?

Many patients with vibratory angioedema have difficulty avoiding the stimuli, particularly relating to their occupation, impacting their lifestyle and ability to socialise.

How is vibratory angioedema diagnosed?

The history of angioedema or erythema after exposure to vibratory stimuli is suspicious of vibratory angioedema. A vibration provocation test is recommended to confirm the diagnosis [9].

Vibration provocation test

A vibratory provocation test is conducted as follows:

  1. Apply a vortex or mixer on a level plane with the forearm skin
  2. Induce the vibration stimulus for 5 minutes
  3. Assess the skin for angioedema
  4. Monitor the site for 4-6 hours as a delayed response occurs in some patients [10].

Patients should avoid antihistamines for several days prior to testing.

Other provocation tests should be conducted to exclude other forms of chronic inducible urticaria if the results are equivocal.

What is the differential diagnosis for vibratory angioedema?

Other causes of inducible angioedema and urticaria include the following.

Classification of inducible urticaria is according to the stimulus or stimuli that provoke the urticaria confirmed with an appropriate provocation test.

What is the treatment for vibratory angioedema?

The mainstay of treatment is to avoid vibratory stimuli where possible. Patients should be reminded of the risk of prolonged or intense exposure to vibration leading to more significant systemic involvement.

Symptomatic management focuses on the use of second-generation non-sedating H1 antihistamines, such as loratadine and cetirizine [11].

What is the outcome for vibratory angioedema?

Vibratory angioedema generally resolves with symptomatic treatment and avoidance of physical stimuli.

The rate of complete spontaneous resolution is unknown.

See smartphone apps to check your skin.
[Sponsored content]

 

Related information

 

 

References

  1. Kaplan AP, Greenberger PA, Geller M.Vibratory urticaria and ADGRE2. N Engl J Med. 2016;375(1):94-5. doi:10.1056/NEJMc1604757.  PubMed
  2. Patterson R, Mellies CJ, Blankenship ML, Pruzansky JJ. Vibratory angioedema: a hereditary type of physical hypersensitivity. J Allergy Clin Immunol. 1972;50(3):174-82. doi:10.1016/0091-6749(72)90048-6. PubMed
  3. Ting S, Reimann BE, Rauls DO, Mansfield LE. Nonfamilial, vibration-induced angioedema. J Allergy Clin Immunol. 1983;71(6):546-51. doi:10.1016/0091-6749(83)90435-9. PubMed
  4. Boyden SE, Desai A, Cruse G et al. Vibratory urticaria associated with a missense variant in ADGRE2. N Engl J Med. 2016;374(7):656-63. doi:10.1056/NEJMoa1500611. PubMed Central
  5. Sarmast SA, Fang F, Zic J. Vibratory angioedema in a trumpet professor. Cutis 2014; 93: E10–1. PubMed
  6. Patruno C, Ayala F, Cimmino G, Mordente I, Balato N. Vibratory angioedema in a saxophonist. Dermatitis 2009; 20: 346–7. PubMed
  7. Kalathoor I. Snoring-induced vibratory angioedema. Am J Case Rep. 2015;16:700-2. doi:10.12659/AJCR.894636. PubMed Central
  8. Alpern ML, Campbell RL, Rank MA, Park MA, Hagan JB. A case of vibratory anaphylaxis. Ann Allergy Asthma Immunol. 2016;116(6):588-9. doi:10.1016/j.anai.2016.04.009.  PubMed
  9. Zuberbier T, Aberer W, Asero R et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-414. doi:10.1111/all.13397. PubMed
  10. Keahey TM, Indrisano J, Lavker RM, Kaliner MA. Delayed vibratory angioedema: insights into pathophysiologic mechanisms. J Allergy Clin Immunol. 1987;80(6):831-38. doi:10.1016/s0091-6749(87)80273-7.  PubMed
  11. Abajian M, Schoepke N, Altrichter S, Zuberbier T, Maurer M. Physical urticarias and cholinergic urticaria [published correction appears in Immunol Allergy Clin North Am. 2014 May;34(2):xix. Zuberbier, H C Torsten [corrected to Zuberbier, Torsten]]. Immunol Allergy Clin North Am. 2014;34(1):73-88. doi:10.1016/j.iac.2013.09.010. PubMed

On DermNet NZ

Other websites

Books about skin diseases